<?xml version='1.0' encoding='utf-8'?>
<document id="31676845"><sentence text="Rapid maturation of the hepatic cell line Huh7 via CDK inhibition for PXR dependent CYP450 metabolism and induction." /><sentence text="CYP3A4, a cytochrome P450 enzyme regulated by the nuclear receptor PXR, is involved in most of the drug metabolizing pathways" /><sentence text=" Studying the regulation/induction of CYP3A4 and PXR is critical in toxicology and drug-drug interaction (DDI) studies" /><sentence text=" Primary human hepatocytes constitute the preferred in vitro platform for drug development efforts" /><sentence text=" However, they are expensive, scarce and heterogeneous" /><sentence text=" Hepatic cell lines, such as Huh7, could provide a cost-effective alternative, however, they express negligible amounts of CYP450s and PXR" /><sentence text=" In this study, we show that dinaciclib, a potent cyclin dependent kinase inhibitor, significantly increases the basal CYP3A4 and PXR levels in 24 hours"><entity charOffset="29-39" id="DDI-PubMed.31676845.s7.e0" text="dinaciclib" /></sentence><sentence text=" We also demonstrated that matured Huh7s can be used for drug induction studies, where CYP3A4, CYP1A2, CYP2C9, and CYP2C19 inductions were achieved following rifampicin treatment"><entity charOffset="158-168" id="DDI-PubMed.31676845.s8.e0" text="rifampicin" /></sentence><sentence text=" More importantly, through a direct demonstration using amiodarone and rifampicin as model drugs, we showed that matured Huh7s present a suitable platform for DDI studies"><entity charOffset="56-66" id="DDI-PubMed.31676845.s9.e0" text="amiodarone" /><entity charOffset="71-81" id="DDI-PubMed.31676845.s9.e1" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.31676845.s9.e0" e2="DDI-PubMed.31676845.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31676845.s9.e0" e2="DDI-PubMed.31676845.s9.e1" /></sentence><sentence text="" /></document>